Research Journal of Pharmacy and Technology
SCOPUS
  • Year: 2022
  • Volume: 15
  • Issue: 12

A Brief Review on Lysozyme’s Pharmacology and Drug-Carrying Capacity

  • Author:
  • Punit Dilip Varma1,2, Yogita Deoprasad Shahu1,3, Subhash Yende1, Sumit Kishan Arora1, Pranali Mishra4, Shailesh Jain5, Ankit Mishra4,*
  • Total Page Count: 9
  • Page Number: 5886 to 5894

1Gurunank College of Pharmacy, Kamptee Road, Nagpur, MS440026.

2Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research, SAS Nagar, Mohali, PB160062.

3Poona College of Pharmacy, Bharti Vidyapeeth Deemed University, Pune, MS411038.

4Faculty of Pharmacy, VNS Group of Institutions, Neelbud, Bhopal, MP462042.

5Faculty of Pharmacy, SAM Global University, Raisen Road, Bhopal, MP462021.

*Corresponding Author E-mail: mishraaa@gmail.com

Online Published on 06 March, 2023.

Abstract

In recent years, the repurposing of drugs has been one of the exciting work areas for pharmaceutical scientists worldwide. We have prepared a review on Lysozyme, which will help scientists in this area review its properties. Lysozyme is an endogenous enzymatic peptide present in almost every living thing. It has wide therapeutic uses, including antibacterial, antiviral, anti-inflammatory, and immunomodulatory effects. It is showing prominent uses in various diseases, alone or along with other drugs. It is also used as a drug carrier for kidney targeting. It is categorized as generally referred to as safe by USFDA and EC. It is available on the market as oral formulations. Its traditional production by chicken egg is now a day swapped by recombinant production technologies, including transgenic animals. It has a great potential to be studied for various other activities. This review will help the researchers in selecting the medicament for further scientific evaluations.

Keywords

Lysozyme, Antibacterial activity, Muramidase, Chicken egg lysozyme, Drug carrier, Transgenic production